Article
Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsis.
Critical care (London, England) - 4 Oct 2012
Alfieri Alessio, Watson Jay J, Kammerer Richard A, Tasab Mohammed, Progias Pavlos, Reeves Kimberly, Brown Nicola J, Brookes Zoe L
Abstract excerpt
INTRODUCTION: Severe sepsis is characterised by intravascular or extravascular infection with microbial agents, systemic inflammation and microcirculatory dysfunction, leading to tissue damage, organ failure and death. The growth factor angiopoietin (Ang-1) has therapeutic potential but recombinant Ang-1 tends to aggregate and has a short half-life in vivo. This study aimed to investigate the acute effects of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
